Cancer Medicine Journal


Cancer Medicine Journal (DOI prefix: 10.46619) (Impact Factor: 3.2) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.

Cancer Medicine Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.

At this stage, the submission and publication of manuscripts is at discount for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS,

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC
Get the latest research

Acceptance Rate
Days to process
Days to publish
Total Articles

Recently Published Articles

Review Article | Volume 5, Issue 1 | Open Access
Efficacy of Bamlanivimab in Cancer Patients with COVID-19

Patricia A Brock, Adriana H Wechsler, Anne-Marie Chaftari, Hiba Dagher, Ying Jiang, Demis N Lipe, Patrick Chaftari, Susan Gaeta, Tami Johnson, Daniel Coussirat, Alexandre E Malek, Ray Hachem, and Issam Raad

Mini Review | Volume 5, Issue 2 | Open Access
Application Technique in Isolation and Separating Cell for Biomedical Research: A Review Article

Nanda Rachmad Putra Gofur, Aisyah Rachmadani Putri Gofur, Soesilaningtyas, Rizki Nur Rachman Putra Gofur, Mega Kahdina, Hernalia Martadila Putri

Case Report | Volume 5, Issue 2 | Open Access
Metastatic Primary Neuroendocrine Carcinoma of the Breast: A Case Report Describing Successful Treatment using Letrozole and Abemaciclib Combination Therapy

Keyur Thakar, Margaret Gallagher, Pond, Kelleman and Muhammad Wasif Saif

Research Article | Volume 5, Issue 2 | Open Access
To Compare Dose Volume Histograms of Computed Tomography Based 3-Dimensional Treatment Planning with International Commission on Radiation Units

Abhishek Purkayastha, Arumugham Balraj, Saurabh Jaiswal, Virender Suhag, Sachin Taneja, and Mayuri Jain

Short Communication | Volume 5, Issue 2 | Open Access
Role of Cytology in Cancer Screening (The Citiscreen Experience)

BM Petrikovsky

Review Article | Volume 5, Issue 1 | Open Access
The Evolving Role of PD-L1 Inhibition in Non-Small Cell Lung Cancer: A Review of Durvalumab and Avelumab

Melissa Neumann, Neal Murphy and Nagashree Seetharamu

Review Article | Volume 5, Issue 1 | Open Access
A Comprehensive Review of Management of Colorectal Liver Mets in the Current Era

Hassan Aziz, Zubair Ahmed, Yi Lee, Gavin Drumm and Wasif M Saif

Short Communication | Volume 5, Issue 1 | Open Access
The Life Switch

Andrew Hague

Review Article | Volume 5, Issue 1 | Open Access
Does Hospital Type Affect Lymph Node Evaluation in Intrahepatic Cholangiocarcinoma? Analysis of the National Cancer Database

Robert Albertian, Li Ding, Stephanie Stemnes, Martin Goodman, Muhammad Wasif Saif and Hassan Aziz

Research Article | Volume 5, Issue 1 | Open Access
Mitomycin-C and Capecitabine (MIXE) Regimen as Salvage Therapy for Advanced Pancreatic Cancer

Shreya Prasad Goyal, Keyur Thakar, Su Yun Chung, Jyothi Jose and Muhammad Wasif Saif

Aims & Scope

Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.

The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals